Resmiterom Efficacy & Safety in Patients With MASH
Status:
NOT_YET_RECRUITING
Trial end date:
2026-07-31
Target enrollment:
Participant gender:
Summary
Phase 4 clinical trial study aims to further evaluate the safety and therapeutic efficacy of Resmetirom in Pakistani patients with fibroscan proven MASH.